PromarkerD at the American Diabetes Association’s 81st Scientific Sessions

Proteomics International showcased PromarkerD at the American Diabetes Association’s 81st Scientific Sessions, the largest US diabetes conference from 25^th–29^th of June 2021.  Approximately 12,500 attendees attended the virtual conference to learn about the latest developments in the diabetes continuum of care.

The company presented a health economics poster abstract at the conference detailing the potential of PromarkerD to result in net savings to Medicare and commercial insurers of USD384 billion over 10 years.

Learn more about PromarkerD at promarkerd.com